Electrical Equipment & Parts
Compare Stocks
4 / 10Stock Comparison
ULBI vs CBAT vs MVST vs FLUX
Revenue, margins, valuation, and 5-year total return — side by side.
Electrical Equipment & Parts
Electrical Equipment & Parts
Electrical Equipment & Parts
ULBI vs CBAT vs MVST vs FLUX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Electrical Equipment & Parts | Electrical Equipment & Parts | Electrical Equipment & Parts | Electrical Equipment & Parts |
| Market Cap | $149M | $70M | $611M | $23M |
| Revenue (TTM) | $187M | $162M | $428M | $51M |
| Net Income (TTM) | $2M | $-7M | $-29M | $-6M |
| Gross Margin | 23.9% | 10.8% | 28.6% | 32.1% |
| Operating Margin | 3.3% | -10.5% | 1.6% | -1.9% |
| Forward P/E | 6.9x | 6.0x | 35.5x | — |
| Total Debt | $58M | $30M | $186M | $16M |
| Cash & Equiv. | $7M | $7M | $105M | $1M |
ULBI vs CBAT vs MVST vs FLUX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 20 | May 26 | Return |
|---|---|---|---|
| Ultralife Corporati… (ULBI) | 100 | 94.5 | -5.5% |
| CBAK Energy Technol… (CBAT) | 100 | 119.0 | +19.0% |
| Microvast Holdings,… (MVST) | 100 | 20.9 | -79.1% |
| Flux Power Holdings… (FLUX) | 100 | 16.8 | -83.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ULBI vs CBAT vs MVST vs FLUX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ULBI carries the broadest edge in this set and is the clearest fit for long-term compounding and defensive.
- 71.5% 10Y total return vs CBAT's -69.9%
- Beta 1.50, current ratio 3.32x
- 0.9% margin vs FLUX's -12.5%
- +53.6% vs FLUX's -31.9%
CBAT is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 1 yrs, beta 1.05
- Lower volatility, beta 1.05, Low D/E 25.1%, current ratio 0.82x
- Better valuation composite
- Beta 1.05 vs MVST's 2.45, lower leverage
MVST is the clearest fit if your priority is growth exposure.
- Rev growth 12.6%, EPS growth 85.2%, 3Y rev CAGR 27.9%
- 12.6% revenue growth vs CBAT's -13.6%
FLUX lags the leaders in this set but could rank higher in a more targeted comparison.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.6% revenue growth vs CBAT's -13.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 0.9% margin vs FLUX's -12.5% | |
| Stability / Safety | Beta 1.05 vs MVST's 2.45, lower leverage | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +53.6% vs FLUX's -31.9% | |
| Efficiency (ROA) | 0.8% ROA vs FLUX's -21.0%, ROIC 4.5% vs -30.1% |
ULBI vs CBAT vs MVST vs FLUX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
ULBI vs CBAT vs MVST vs FLUX — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBAT leads in 2 of 6 categories
ULBI leads 1 • MVST leads 0 • FLUX leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — ULBI and MVST each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MVST is the larger business by revenue, generating $428M annually — 8.4x FLUX's $51M. ULBI is the more profitable business, keeping 0.9% of every revenue dollar as net income compared to FLUX's -12.5%. On growth, CBAT holds the edge at +36.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $187M | $162M | $428M | $51M |
| EBITDAEarnings before interest/tax | $12M | -$8M | $32M | -$212,000 |
| Net IncomeAfter-tax profit | $2M | -$7M | -$29M | -$6M |
| Free Cash FlowCash after capex | $9M | -$8M | $56M | -$7M |
| Gross MarginGross profit ÷ Revenue | +23.9% | +10.8% | +28.6% | +32.1% |
| Operating MarginEBIT ÷ Revenue | +3.3% | -10.5% | +1.6% | -1.9% |
| Net MarginNet income ÷ Revenue | +0.9% | -4.0% | -6.8% | -12.5% |
| FCF MarginFCF ÷ Revenue | +4.8% | -5.1% | +13.1% | -14.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +21.5% | +36.5% | -15.0% | -60.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.8% | — | +119.2% | -25.0% |
Valuation Metrics
CBAT leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 6.0x trailing earnings, CBAT trades at a 67% valuation discount to ULBI's 18.6x P/E. On an enterprise value basis, CBAT's 5.2x EV/EBITDA is more attractive than MVST's 99.0x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $149M | $70M | $611M | $23M |
| Enterprise ValueMkt cap + debt − cash | $200M | $94M | $692M | $37M |
| Trailing P/EPrice ÷ TTM EPS | 18.55x | 6.04x | -21.00x | -3.25x |
| Forward P/EPrice ÷ next-FY EPS est. | 6.94x | — | 35.50x | — |
| PEG RatioP/E ÷ EPS growth rate | 5.31x | — | — | — |
| EV / EBITDAEnterprise value multiple | 14.18x | 5.22x | 99.04x | — |
| Price / SalesMarket cap ÷ Revenue | 0.90x | 0.40x | 1.43x | 0.34x |
| Price / BookPrice ÷ Book value/share | 0.88x | 0.59x | 1.49x | — |
| Price / FCFMarket cap ÷ FCF | 10.11x | 3.13x | 10.89x | — |
Profitability & Efficiency
CBAT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
ULBI delivers a 1.3% return on equity — every $100 of shareholder capital generates $1 in annual profit, vs $-7 for FLUX. CBAT carries lower financial leverage with a 0.25x debt-to-equity ratio, signaling a more conservative balance sheet compared to MVST's 0.45x. On the Piotroski fundamental quality scale (0–9), CBAT scores 7/9 vs ULBI's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +1.3% | -5.5% | -7.4% | -7.4% |
| ROA (TTM)Return on assets | +0.8% | -2.0% | -2.9% | -21.0% |
| ROICReturn on invested capital | +4.5% | +4.6% | +0.9% | -30.1% |
| ROCEReturn on capital employed | +5.8% | +7.0% | +1.2% | — |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.44x | 0.25x | 0.45x | — |
| Net DebtTotal debt minus cash | $52M | $23M | $81M | $15M |
| Cash & Equiv.Liquid assets | $7M | $7M | $105M | $1M |
| Total DebtShort + long-term debt | $58M | $30M | $186M | $16M |
| Interest CoverageEBIT ÷ Interest expense | 1.60x | -24.86x | -16.53x | -2.64x |
Total Returns (Dividends Reinvested)
ULBI leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ULBI five years ago would be worth $9,004 today (with dividends reinvested), compared to $1,358 for FLUX. Over the past 12 months, ULBI leads with a +53.6% total return vs FLUX's -31.9%. The 3-year compound annual growth rate (CAGR) favors ULBI at 21.4% vs FLUX's -30.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +24.8% | -8.7% | -33.0% | -8.5% |
| 1-Year ReturnPast 12 months | +53.6% | -6.9% | -2.1% | -31.9% |
| 3-Year ReturnCumulative with dividends | +78.9% | +2.0% | +58.8% | -66.1% |
| 5-Year ReturnCumulative with dividends | -10.0% | -81.0% | -84.4% | -86.4% |
| 10-Year ReturnCumulative with dividends | +71.5% | -69.9% | -80.7% | -69.0% |
| CAGR (3Y)Annualised 3-year return | +21.4% | +0.7% | +16.7% | -30.3% |
Risk & Volatility
Evenly matched — ULBI and CBAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
CBAT is the less volatile stock with a 1.05 beta — it tends to amplify market swings less than MVST's 2.45 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ULBI currently trades 74.1% from its 52-week high vs FLUX's 17.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.44x | 1.01x | 2.42x | 2.23x |
| 52-Week HighHighest price in past year | $9.52 | $1.25 | $7.12 | $7.55 |
| 52-Week LowLowest price in past year | $4.50 | $0.77 | $1.37 | $0.97 |
| % of 52W HighCurrent price vs 52-week peak | +74.1% | +62.8% | +26.5% | +17.2% |
| RSI (14)Momentum oscillator 0–100 | 47.3 | 39.6 | 54.4 | 57.8 |
| Avg Volume (50D)Average daily shares traded | 45K | 111K | 3.9M | 114K |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: ULBI as "Buy", MVST as "Buy".
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | — | Buy | — |
| Price TargetConsensus 12-month target | — | — | $4.80 | — |
| # AnalystsCovering analysts | 2 | — | 6 | — |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 1 | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% |
CBAT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). ULBI leads in 1 (Total Returns). 2 tied.
ULBI vs CBAT vs MVST vs FLUX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ULBI or CBAT or MVST or FLUX a better buy right now?
For growth investors, Microvast Holdings, Inc.
(MVST) is the stronger pick with 12. 6% revenue growth year-over-year, versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). CBAK Energy Technology, Inc. (CBAT) offers the better valuation at 6. 0x trailing P/E, making it the more compelling value choice. Analysts rate Ultralife Corporation (ULBI) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ULBI or CBAT or MVST or FLUX?
On trailing P/E, CBAK Energy Technology, Inc.
(CBAT) is the cheapest at 6. 0x versus Ultralife Corporation at 18. 6x. On forward P/E, Ultralife Corporation is actually cheaper at 6. 9x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — ULBI or CBAT or MVST or FLUX?
Over the past 5 years, Ultralife Corporation (ULBI) delivered a total return of -10.
0%, compared to -86. 4% for Flux Power Holdings, Inc. (FLUX). Over 10 years, the gap is even starker: ULBI returned +45. 3% versus MVST's -78. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ULBI or CBAT or MVST or FLUX?
By beta (market sensitivity over 5 years), CBAK Energy Technology, Inc.
(CBAT) is the lower-risk stock at 1. 01β versus Microvast Holdings, Inc. 's 2. 42β — meaning MVST is approximately 140% more volatile than CBAT relative to the S&P 500. On balance sheet safety, CBAK Energy Technology, Inc. (CBAT) carries a lower debt/equity ratio of 25% versus 45% for Microvast Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ULBI or CBAT or MVST or FLUX?
By revenue growth (latest reported year), Microvast Holdings, Inc.
(MVST) is pulling ahead at 12. 6% versus -13. 6% for CBAK Energy Technology, Inc. (CBAT). On earnings-per-share growth, the picture is similar: CBAK Energy Technology, Inc. grew EPS 574. 5% year-over-year, compared to -13. 6% for Ultralife Corporation. Over a 3-year CAGR, CBAT leads at 49. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ULBI or CBAT or MVST or FLUX?
CBAK Energy Technology, Inc.
(CBAT) is the more profitable company, earning 6. 7% net margin versus -10. 0% for Flux Power Holdings, Inc. — meaning it keeps 6. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ULBI leads at 6. 1% versus -7. 6% for FLUX. At the gross margin level — before operating expenses — FLUX leads at 32. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ULBI or CBAT or MVST or FLUX more undervalued right now?
On forward earnings alone, Ultralife Corporation (ULBI) trades at 6.
9x forward P/E versus 35. 5x for Microvast Holdings, Inc. — 28. 6x cheaper on a one-year earnings basis.
08Which pays a better dividend — ULBI or CBAT or MVST or FLUX?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is ULBI or CBAT or MVST or FLUX better for a retirement portfolio?
For long-horizon retirement investors, CBAK Energy Technology, Inc.
(CBAT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 01)). Microvast Holdings, Inc. (MVST) carries a higher beta of 2. 42 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CBAT: -69. 7%, MVST: -78. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ULBI and CBAT and MVST and FLUX?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ULBI is a small-cap quality compounder stock; CBAT is a small-cap deep-value stock; MVST is a small-cap quality compounder stock; FLUX is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.